摘要
目的探析阿托伐他汀对慢性硬膜下血肿钻孔引流术后复发率的影响。方法选取2015年1月-2019年5月郑州人民医院收治的慢性硬膜下血肿病人80例,随机分为研究组与对照组,每组各40例;两组均行钻孔引流术。研究组患者在钻孔引流术后第一天开始口服阿托伐他汀钙片(立普妥,20mg,qd),对比两组患者的疗效和术后复发情况。结果两组有效性对比差异无统计学意义(P>0.05);两组术后复发率对比差异有统计学意义(P<0.05)。结论阿托伐他汀钙片能够有效降低慢性硬膜下血肿钻孔引流术后复发率。
Objective To investigate the effect of atorvastatin on the recurrence rate after drilling and drainage of chronic subdural hematoma.Methods 80 patients with CSDH admitted to Zhengzhou People's Hospital from January 2015 to May 2019 were choosed and randomly divided into the observation group and the control group,with 40 cases in each group.Patients in the study group began to take atorvastatin calcium tablets(lipitor,20mg,qd)orally on the 1st day after drilling and drainage,and the efficacy and postoperative recurrence of the two groups were compared.Results There was no statistically significant differences between two groups of the effectiveness(P>0.05).The differences of the recurrence between two groups are statistically significant(P<0.05).Conclusion Atorvastatin can effectively reduce the rate of postoperative recurrence rate of chronic subdural hematoma.
作者
邵冰水
SHAO Bingshui(Department of Neurosurgery,Zhengzhou People's Hospital,Zhengzhou Henan 450000,China)
出处
《临床研究》
2020年第4期38-40,共3页
Clinical Research